Page last updated: 2024-10-28

hydroxyurea and Mastocytosis

hydroxyurea has been researched along with Mastocytosis in 2 studies

Mastocytosis: A rare neoplastic disorder characterized by a clonal proliferation of MAST CELLS, associated with KIT-D816 mutations, and accompanied by aberrant mast cell activation. The abnormal increase of MAST CELLS may occur in only the skin (MASTOCYTOSIS, CUTANEOUS), in extracutaneous tissues involving multiple organs (MASTOCYTOSIS, SYSTEMIC), or in solid tumors (MASTOCYTOMA).

Research Excerpts

ExcerptRelevanceReference
"Patients with clonal mast cell activation syndromes (MCAS) including cutaneous and systemic mastocytosis (SM) may present with symptoms of mast cell activation, but in addition can have organ damage from the local effects of tissue infiltration by clonal mast cells."2.61Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management. ( Butterfield, J; Castells, M, 2019)
"Some sickle cell anemia (SCA) patients suffer significantly worse phenotypes than others."1.40Mast cell activation syndrome as a significant comorbidity in sickle cell disease. ( Afrin, LB, 2014)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Castells, M1
Butterfield, J1
Afrin, LB1

Reviews

1 review available for hydroxyurea and Mastocytosis

ArticleYear
Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management.
    The journal of allergy and clinical immunology. In practice, 2019, Volume: 7, Issue:4

    Topics: Anti-Allergic Agents; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cromo

2019

Other Studies

1 other study available for hydroxyurea and Mastocytosis

ArticleYear
Mast cell activation syndrome as a significant comorbidity in sickle cell disease.
    The American journal of the medical sciences, 2014, Volume: 348, Issue:6

    Topics: Adult; Anemia, Sickle Cell; Antisickling Agents; Caseins; Chromogranin A; Cohort Studies; Female; He

2014
chemdatabank.com